• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征垂体抑制后,人绝经期促性腺激素与促卵泡激素刺激的比较

Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome.

作者信息

Tanbo T, Dale P O, Kjekshus E, Haug E, Abyholm T

机构信息

National Hospital, University of Oslo, Norway.

出版信息

Fertil Steril. 1990 May;53(5):798-803. doi: 10.1016/s0015-0282(16)53512-2.

DOI:10.1016/s0015-0282(16)53512-2
PMID:2110071
Abstract

Stimulation with human menopausal gonadotropin (hMG) or follicle-stimulating hormone (FSH) was compared in 34 patients with polycystic ovarian syndrome after pituitary gonadotrope suppression with buserelin acetate. No differences were seen in the hormone parameters observed. Also, the duration of the stimulation period and the dose of gonadotropin used were the same. In both groups a multifollicular response was seen. Oocyte retrieval and in vitro fertilization resulted in identical ratios of mature to total oocytes and cleavage rates. Nine pregnancies occurred, four in the hMG group and five in the FSH group. Of the nine pregnancies, two were the result of transfer of frozen-thawed embryos in estradiol and progesterone substituted cycles.

摘要

在34例多囊卵巢综合征患者中,使用醋酸布舍瑞林抑制垂体促性腺激素后,比较了人绝经期促性腺激素(hMG)和促卵泡激素(FSH)刺激的效果。观察到的激素参数没有差异。此外,刺激期的持续时间和使用的促性腺激素剂量相同。两组均出现多卵泡反应。取卵和体外受精产生的成熟卵母细胞与总卵母细胞的比率以及卵裂率相同。共发生9例妊娠,hMG组4例,FSH组5例。在这9例妊娠中,有2例是在雌激素和孕激素替代周期中移植冻融胚胎的结果。

相似文献

1
Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome.多囊卵巢综合征垂体抑制后,人绝经期促性腺激素与促卵泡激素刺激的比较
Fertil Steril. 1990 May;53(5):798-803. doi: 10.1016/s0015-0282(16)53512-2.
2
Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
J Reprod Med. 1992 Oct;37(10):834-40.
3
Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.多囊卵巢综合征患者皮下脉冲式注射人绝经期促性腺激素诱导排卵
Horm Res. 1990;33 Suppl 2:43-8. doi: 10.1159/000181567.
4
Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.多囊卵巢综合征:即使对于既往超反应患者,低剂量促卵泡生成素给药也是一种安全的刺激方案。
Hum Reprod. 1992 Sep;7(8):1085-9. doi: 10.1093/oxfordjournals.humrep.a137797.
5
Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.在体外受精-胚胎移植计划中,醋酸布舍瑞林诱导垂体脱敏期间血清促卵泡生成素与促黄体生成素比值对卵巢对外源性促性腺激素反应的影响。
Hum Reprod. 1996 Aug;11(8):1615-9. doi: 10.1093/oxfordjournals.humrep.a019456.
6
Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.多囊卵巢女性体外受精后的流产率会升高,而使用布舍瑞林进行垂体脱敏可降低流产率。
Hum Reprod. 1993 Jun;8(6):959-64. doi: 10.1093/oxfordjournals.humrep.a138174.
7
A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with Buserelin for superovulation and in vitro fertilization.使用布舍瑞林对垂体进行脱敏后,纯化卵泡刺激素与人类绝经期促性腺激素用于超排卵及体外受精的随机对照研究
Fertil Steril. 1988 Jul;50(1):79-84. doi: 10.1016/s0015-0282(16)60012-2.
8
Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.在体外受精中,垂体抑制后单独使用纯的和高纯度促卵泡激素,或与人类绝经期促性腺激素联合用于卵巢刺激。
Hum Reprod. 1996 Nov;11(11):2400-4. doi: 10.1093/oxfordjournals.humrep.a019123.
9
A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins.使用高纯度促卵泡激素的低剂量刺激方案可使多囊卵巢体外受精患者获得高妊娠率,这些患者存在对促性腺激素产生高卵巢反应的风险。
Fertil Steril. 2001 Jun;75(6):1131-5. doi: 10.1016/s0015-0282(01)01788-5.
10
Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG.用醋酸布舍瑞林-人绝经期促性腺激素(HMG)或枸橼酸氯米芬-HMG刺激卵巢后新鲜和冷冻保存的人胚胎植入的长期评估。
Hum Reprod. 1996 Oct;11(10):2097-106. doi: 10.1093/oxfordjournals.humrep.a019056.

引用本文的文献

1
Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment.多囊卵巢综合征中的不孕症:聚焦于低剂量促性腺激素治疗。
Endocrine. 2006 Aug;30(1):27-33. doi: 10.1385/ENDO:30:1:27.
2
A randomized prospective cross-over study of highly purified follicle-stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in women aged 37-41 years.一项关于高纯度促卵泡生成素和人绝经期促性腺激素用于37 - 41岁女性卵巢过度刺激的随机前瞻性交叉研究。
J Assist Reprod Genet. 2000 Feb;17(2):107-12. doi: 10.1023/a:1009418017662.
3
Polycystic ovarian disease (PCOD)--pregnancy rate and outcome in in vitro fertilization.
J Assist Reprod Genet. 1993 Jan;10(1):11-4. doi: 10.1007/BF01204434.